Phase 1 Study of Pemigatinib in Patients With Advanced Malignancies With FGF/FGFR Alterations
Clinical trial NCT04258527 · COMPLETED
Trial details
- NCT number
- NCT04258527
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-26
- Primary completion
- 2020-07-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.